Home/Filings/4/0001404219-09-000011
4//SEC Filing

JUELSGAARD STEPHEN G 4

Accession 0001404219-09-000011

CIK 0000318771other

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 9:45 PM ET

Size

16.4 KB

Accession

0001404219-09-000011

Insider Transaction Report

Form 4
Period: 2009-03-26
JUELSGAARD STEPHEN G
EVP, CCO & SECRETARY
Transactions
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2009-03-26200,0000 total
    Exercise: $42.05From: 2003-09-11Exp: 2013-09-11Common Stock (200,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2009-03-26200,0000 total
    Exercise: $53.23From: 2004-09-23Exp: 2014-09-23Common Stock (200,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2009-03-26125,0000 total
    Exercise: $79.55From: 2008-09-20Exp: 2017-09-20Common Stock (125,000 underlying)
  • Disposition to Issuer

    Common Stock

    2009-03-26$95.00/sh5,766$547,7700 total
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2009-03-26135,0000 total
    Exercise: $79.17From: 2007-09-20Exp: 2016-09-20Common Stock (135,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2009-03-26165,0000 total
    Exercise: $85.83From: 2005-09-23Exp: 2015-09-23Common Stock (165,000 underlying)
Footnotes (4)
  • [F1]Disposed of pursuant to the Agreement and Plan of Merger between the issuer, Roche Holdings Inc. and Roche Investments USA dated March 12, 2009.
  • [F2]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
  • [F3]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
  • [F4]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.

Issuer

GENENTECH INC

CIK 0000318771

Entity typeother

Related Parties

1
  • filerCIK 0001214125

Filing Metadata

Form type
4
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 9:45 PM ET
Size
16.4 KB